Variables | No* | Sample | OR (95% CI) | I2 (%) | P-value |
---|---|---|---|---|---|
ART adherence | |||||
 Good | 5 | 6080 | 1 | 98.1 | < 0.001 |
 Poor/fair |  |  | 6.60 (1.41–30.97)** |  |  |
Functional status | |||||
 Working | 12 | 9954 | 1 | 92.1 | < 0.001 |
 Ambulatory/bedridden |  |  | 2.11 (1.33–3.34)** |  |  |
Opportunistic disease | |||||
 Yes | 8 | 7574 | 1 | 94.3 | < 0.001 |
 No |  |  | 0.52 (0.30–0.90)** |  |  |
Recorded appointment |  |  |  |  | < 0.001 |
 Yes | 2 | 2518 | 1 | 97.6 |  |
 No |  |  | 0.7 (0.17–2.88) |  |  |
BMI | |||||
 Normal (> 18.5) | 4 | 2260 | 1 | 70.7 | 0.017 |
 Underweight (< 18.5) |  |  | 2.21 (1.45–3.39)** |  |  |
side effects | |||||
 Yes | 2 | 1196 | 1 | 98.8 | < 0.001 |
 No |  |  | 0.83 (0.03–26.98) |  |  |
INH | |||||
 Took INH | 4 | 2275 | 1 | 97.7 | < 0.001 |
 Not took INH |  |  | 3.42 (0.57–20.51) |  |  |
Health facility | |||||
 Health center | 2 | 11,717 | 1 | 84.5 | 0.011 |
 Hospital |  |  | 1.23 (0.58–2.62) |  |  |
Baseline WHO stage | |||||
 I and II | 12 | 21,509 | 1 | 92 | < 0.001 |
 III and IV |  |  | 1.85 (1.36–2.51)** |  |  |
Baseline CD4 level | |||||
  < 200 | 8 | 19,134 | 1 | 98.3 | < 0.001 |
  > 200 |  |  | 1.09 (0.49–2.41) |  |  |
Hemoglobin | |||||
 Anemic (< 10 g/ml) | 2 | 815 | 1 | 0 | 0.35 |
 Normal (> 10 g/ml) |  |  | 0.29 (0.20–0.42)** |  |  |